title: Management of patients with thyroid eye disease.
authors.affiliation: Consultant in Diabetes and Endocrinology at the Royal Free Hospital NHS Trust, London NW3 2QG.
authors.forename: Efthimia
authors.initials: E
authors.lastname: Karra
authors.affiliation: Consultant Physician in Diabetes and Endocrinology at Ashford and St Peter's Hospital, Chertsey, Surrey.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Yousseif
authors.affiliation: Consultant Ophthalmologist at Moorfields Eye Hospital, London.
authors.forename: Geoffrey E
authors.initials: GE
authors.lastname: Rose
authors.affiliation: Consultant Physician in Diabetes and Endocrinology at University College London Hospital, London.
authors.forename: Stephanie E
authors.initials: SE
authors.lastname: Baldeweg
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D017115:Catheter Ablation / Q000379:methods; D049970:Graves Ophthalmopathy / Q000628:therapy*; D020249:Hormone Replacement Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069283:Rituximab / Q000627:therapeutic use; D016540:Smoking Cessation; D013518:Surgery, Plastic / Q000379:methods; D013974:Thyroxine / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D000069283:Rituximab; D013974:Thyroxine